Sharieff 2006a.
Methods |
Study design: randomised placebo‐controlled trial Unit and method of allocation: individual Method of sequence generation: computer‐generated random selection of children from each geographical zone Masking of participants, personnel, and outcome assessors: study participants, field staff, and data analyst were blinded |
|
Participants |
Location of the study: Bilal Colony, an urban slum neighbourhood in Karachi, Pakistan Sample size: 75 infants Age: 6 to 12 months Sex: 56% boys in micronutrient group, 28% boys in control group Socioeconomic status: similar at baseline between groups (report ethnicity, maternal education, family income, housing structure) Baseline prevalence of anaemia: not reported Baseline prevalence of soil helminths: not reported Baseline malaria prevalence: not reported Inclusion and exclusion criteria: inclusion criteria included intent to reside in the area for 2 or more months, parental consent, and child able to ingest any type of semi‐solid weaning food, 1 or more episode of diarrhoea within previous 2 weeks |
|
Interventions | Participants were randomly assigned to 1 of 3 groups Interventions
Comparison Group 3* (n = 25): children received daily placebo (containing ground purple rice with maltodextrin) Interventions were provided in small screw‐cap plastic containers with powders that were similar in appearance and taste; mothers and caregivers were instructed to open the containers and mix the entire contents with semi‐solid meal provided to the child once each day *For the purposes of this review, only groups 1 and 3 were compared Duration of intervention: 2 months |
|
Outcomes |
Primary: longitudinal prevalence of diarrhoea (defined as 3 or more liquid or loose stools in the past 24 hours). Longitudinal prevalence was defined as percentage of days that the child had diarrhoea over the observation period Secondary: febrile days per child, compliance, haemoglobin concentrations, serum ferritin concentrations, anaemia, iron deficiency. Stool cultures at baseline (for Salmonella, Shigella, Campylobacter, Yersinia, enteropathic Escherichia coli and Vibrio cholerae, and Giardia lamblia) Timing of outcome assessment: number of diarrhoeal stools, days of diarrhoea, dysentery, vomiting, presence of fever (and intensity and duration), respiratory symptoms, and drug usage assessed twice a week; blood samples collected at end of 2 months |
|
Notes |
Study start date: January 2003 Study end date: March 2003 Conflict(s) of interest: co‐author (S Zlotkin) owns intellectual property rights to micronutrient Sprinkles™ Funding source(s): Canadian Institutes of Health Research, HJ Heinz Foundation, Institut Rosell Lallemand Malaria‐endemic area: yes Comment Compliance was measured by counting the used supplements for each child whose supplements were not shared or lost. 91% of children consumed half of MNP (mean number 36) |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Comment: children assigned to treatment via a computer programme |
Allocation concealment (selection bias) | Low risk | Comment: study authors provided identical, small screw‐cap plastic containers filled with micronutrients (with or without probiotic) or placebo in powder form, which were similar in appearance and taste |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Comment: study authors provided identical, small screw‐cap plastic containers filled with micronutrients (with or without probiotic) or placebo in powder form, which were similar in appearance and taste. Study participants and field staff were blinded to random allocation |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Comment: data analysts blinded to random allocation |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Comment: 1 child dropped out from the intervention group and 1 from the comparison group |
Selective reporting (reporting bias) | Unclear risk | Comment: information insufficient to permit judgement |
Other bias | High risk | Comment: haemoglobin and ferritin were not measured at baseline, making it difficult to judge comparability between groups. Only 61% of the original population agreed to provide a blood sample at the end of the study |